{
  "actions": [
    {
      "acted_at": "1992-09-25", 
      "committee": "House Committee on Judiciary", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Judiciary.", 
      "type": "referral"
    }, 
    {
      "acted_at": "1992-09-28", 
      "in_committee": "House Committee on Judiciary", 
      "references": [], 
      "subcommittee": "Intellectual Property and Judicial Administration", 
      "text": "Referred to the Subcommittee on Intellectual Property and Judicial Administration.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr6038-102", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU", 
      "subcommittee": "Subcommittee on Intellectual Property and Judicial Administration", 
      "subcommittee_id": "03"
    }
  ], 
  "congress": "102", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "1992-09-25", 
  "number": "6038", 
  "official_title": "To amend title 35, United States Code, to permit separate patent extensions for each product under a patent which is subject to full regulatory review and approval.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": null, 
  "sponsor": {
    "district": "27", 
    "name": "Levine, Mel", 
    "state": "CA", 
    "thomas_id": "00684", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "1992-09-25", 
  "subjects": [
    "Administrative procedure", 
    "Colleges", 
    "Drugs", 
    "Patents", 
    "Pharmaceutical research"
  ], 
  "subjects_top_term": "Patents", 
  "summary": {
    "as": "Introduced", 
    "date": "1992-09-25", 
    "text": "Amends Federal patent law to permit separate patent extensions for certain drug products: (1) under a patent which is subject to full regulatory review and approval; and (2) which were developed at a qualified nonprofit institution of higher education."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "To amend title 35, United States Code, to permit separate patent extensions for each product under a patent which is subject to full regulatory review and approval.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:14:59-05:00"
}